In this study, we aimed to utilize the E2A-PBX1 pre-B-ALL cells from an established murine model to develop an Artificial Intelligence (AI)-assisted automated colony forming assay, integrating time-lapse microscopy and microfluidics-based drug screening to facilitate a time efficient method to accurately evaluate the effects of combination therapies. Here, PBX1 is linked to acute lymphoblastic leukemia.